Presented in part at the 3rd Slovenian Congress of Nephrology held 29 September−2 October 2004, in Brdo pri Kranju, Slovenia.
Renal Replacement Therapy in Slovenia: 2003 Annual Report*
Article first published online: 21 JUN 2005
Therapeutic Apheresis and Dialysis
Volume 9, Issue 3, pages 196–201, June 2005
How to Cite
Buturović-Ponikvar, J. and the Expert Group for Dialysis in Slovenia (2005), Renal Replacement Therapy in Slovenia: 2003 Annual Report. Therapeutic Apheresis and Dialysis, 9: 196–201. doi: 10.1111/j.1774-9987.2005.00252.x
Expert Group for Dialysis in Slovenia at the Ministry of Health, Republic of Slovenia. Data were contributed by nephrologists from dialysis centers and the Center for Renal Transplantation: Tone Adamlje, Trbovlje; Danica Blanuša, Ptuj; Zlata Ceglar, Izola; Sonja Cimerman Steklasa, Novo Mesto; Senka Čatak, Naklo; Andrej Čufer, Zreče; Andrej Guček, Ljubljana; Aljoša Kandus, Ljubljana; Sonja Kapun, Krško; Simona Kralj-Lopert, Murska Sobota; Marjeta Lešnik, Celje; Marko Malovrh, Ljubljana; Gregor Novljan, Ljubljana; Karel Pečovnik, Maribor; Rafael Ponikvar, Ljubljana; Nikola Rukavina, Ljubljana; Igor Rus, Jesenice; Silvan Saksida, Nova Gorica; Bojan Vujkovac, SlovenjGradec.
- Issue published online: 21 JUN 2005
- Article first published online: 21 JUN 2005
- Received February 2005.
- End-stage renal disease;
- Kidney transplantation;
- Peritoneal dialysis;
- Renal replacement therapy
Abstract: The total number of end-stage renal disease patients treated by renal replacement therapy increased from 1584 on 31 December 2002 to 1661 on 31 December 2003 (4.9% increase). Of these patients, 70.5% were treated by hemodialysis, 7.0% by peritoneal dialysis and 22.5% had a functioning renal graft. The patients were treated at 18 dialysis centers and one transplant center. The number of prevalent patients treated by renal replacement therapy per million of the population (p.m.p.) was 846 at the end of 2003. The number of incident (new) patients in 2003 was 131 p.m.p. The gross mortality rate of dialysis patients was stable through the years of the study and reached 11.8% in 2003. 57.6% of new patients starting hemodialysis were ≥ 65 years old and 23.2% were diabetics. Epoetin therapy was prescribed to 89.8% of dialysis patients. The number of patients positive for hepatitis B or hepatitis C viruses is stable and low (3.1% of all dialysis patients).